803 results on '"Laks H"'
Search Results
2. Right Ventricular Outflow Tract Transannular Patch Placement without Cardiopulmonary Bypass
3. Donor Brain Death Mechanisms and Outcomes After Heart Transplantation
4. Ethnicity as a Predictor of Graft Longevity and Recipient Mortality in Heart Transplantation
5. Is Third-Time Heart Retransplantation Justifiable?
6. 3D MR imaging of coronary arteriovenous fistulas
7. Pushing the size limits of transplanted hearts
8. Bronchiolitis obliterans with organizing pneumonia: possible association with human herpesvirus-7 infection after lung transplantation
9. חופש, סיבתיות ודטרמניזם בפילוסופיה של הרמב"ם / FREEDOM, CAUSALITY AND DETERMINISM IN THE RAMBAM
10. Use of Valved Conduits to Repair Complex Congenital Heart Defects
11. Servo-Controlled Cardiac Assistance: The Effects of Left Ventricular-to-Aortic and Left Atrial-to-Aortic Assistance on Infarct Size
12. Akute normovolämische Hämodilution bei elektiven chirurgischen Eingriffen
13. Mechanical Circulatory Support for the Fontan Circulation
14. Gene Transfer
15. Selecting Oversized Donor Cardiac Allografts for Patients With Pulmonary Hypertension May Be Unnecessary
16. Creation of a Surgical Fontan Animal Model and the Use of a Ventricular Assist Device to Restore Cardiac Output
17. Cardiac Retransplantation: How Far Have We Come?
18. ACUTE CARDIAC FAILURE: THE IMPORTANCE OF THE RIGHT VENTRICLE
19. A SERVO CONTROLLED TRANSAPICAL LEFT VENTRICULAR TO AORTIC ASSIST DEVICE WITH IMPLANTABLE CANNULAE
20. 457: Does Listing Status Affect Cost of Heart Transplantation?
21. 576: Does Treatment of Sensitized VAD Patients Improved Post Heart Transplant Outcomes?
22. 436: Combined Ex Vivo IL-4 and IL-10 Gene Therapy Reduces Chronic Rejection in Cardiac Allografts
23. 106: Low Strength Electric Field Network-Mediated Ex Vivo IL-4 and IL-10 Combined Gene Therapy Induced Rabbit Cardiac Allograft Tolerance
24. 127: Overexpression of Exogenous IL-4 and IL-10 Synergistically Upregulates Infiltrative CD4+CD25+ T Cells in Cardiac Allografts and Induces Long-Term Allograft Survival
25. 167: Impact of Age on Outcomes of Ventricular Assist Devices Utilized as Bridge to Cardiac Transplantation
26. 248: Tricuspid Valve Regurgitation (TR) after Heart Transplantation Using the Bicaval Anastomosis Technique
27. 288: Improved Clinical Outcomes Using Bi-Ventricular Assist Devices as Bridges to Transplant in Critically Ill Patients
28. 267: ECMO To Salvage Severe Cardiogenic Shock in Advanced Heart Failure and Transplantation
29. 332: Upregulated Transforming Growth Factor-β1 Expression and Distribution in Coronary Arterial Wall from Patients with Cardiac Allograft Vasculopathy Versus Ischemic Cardiomypathy
30. 205: Long Term Outcome of Heart Transplant in the Elderly
31. THE INFLUENCE OF ADVERSE DONOR FACTORS AFFECTING OUTCOME OF PEDIATRIC HEART TRANSPLANTATION: THE MARGINAL DONOR ALLOGRAFT.
32. Five-Year Results of a Randomized, Single-Center Study of Tacrolimus vs Microemulsion Cyclosporine in Heart Transplant Patients
33. 408 AVERAGE FIRST-YEAR BRAIN NATRIURETIC PEPTIDE PREDICTS POOR OUTCOME AFTER HEART TRANSPLANTATION.
34. Hemodynamic Compromise Rejection Predicts Future Cardiac Allograft Vasculopathy and Nonfatal Major Adverse Cardiac Events
35. 528 ARTERIAL SWITCH OPERATION IN INFANTS WITH ABNORMAL CORONARY PATTERNS: CLINICAL OUTCOMES.
36. 506 SURGICAL CREATION OF AUTOLOGOUS PERICARDIAL NEO-AORTIC SINUSES TO MANAGE SINUS OF VALSALVA PATHOLOGY.
37. 233 HEMODYNAMIC COMPROMISE REJECTION PREDICTS FUTURE CARDIAC ALLOGRAFT VASCULOPATHY AND NONFATAL MAJOR ADVERSE CARDIAC EVENTS.
38. Editorial
39. Justification of the newly proposed ISHLT biopsy grading scale by combining grades 1A, 1B, and 2 into one mild rejection grade
40. CABG-patched donor hearts: The long term outcome
41. Caution using a calcineurin inhibitor-free renal sparing protocol for heart transplant patients with renal dysfunction
42. Should humoral rejection be included in the new ISHLT biopsy grading scale?
43. Long-term outcome of alternate list heart transplant patients
44. Downreguration of CD8+ T cell cytotoxicity via perforin/ granzyme B pathway protects cardiac allograft myocytes in interleukin-4 and -10 combined gene therapy
45. The Influence of Adverse Donor Factors on Outcome of Pediatric Heart Transplantation – the Marginal Donor Allograft
46. Bypassed Donor Hearts: The Long Term Outcome after Heart Transplantation
47. 389 ENDOCARDIAL VERSUS EPICARDIAL PERMANENT PACING IN CHILDREN
48. 109 SURGICAL CORRECTION OF ANEURYSMS OF THE SINUS OF VALSALVA IN THE 21ST CENTURY
49. Cardiac Repair under Cardiopulmonary Bypass in Children with End-Stage Liver Disease
50. 106 THE FATE OF OLDER DONOR CARDIAC ALLOGRAFTS IN ADOLESCENT RECIPIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.